Prescription Drug Information and News

Our PacificSource Drug Lists are updated monthly.
Learn more about our PacificSource Drug Lists >  

Our drug lists are available in a searchable online format. Find a Drug >   

Preferred Drug List (PDL) Changes

June 2017. The following changes to the drug list are effective June 22, 2017:  

Formulary Additions

  • Kisqali tablet add Tier 3, Specialty, and preauthorization
  • Xultophy subcutaneous injection add Tier 3 with medical necessity preauthorization
  • Lopinavir-Ritonavir oral solution add Tier 1
  • Aprepitant oral capsule add Tier 1 with quantity limit
  • Dexmethylphenidate ER capsule add Tier 1 with quantity limit
  • RyVent add Tier 3 with medical necessity preauthorization
  • Emflaza add Tier 3, Specialty, and medical necessity preauthorization
  • Eucrisa 2% external ointment add Tier 3 with medical necessity preauthorization
  • Vyvanse chewable tablet add Tier 3
  • Arymo ER add Tier 3 with medical necessity preauthorization
  • Trulance tablet add Tier 3 with medical necessity preauthorization and quantity limit

Removed from Formulary

  • Travoprost ophthalmic solution; Product discontinued consider Latanoprost

Tier Change

  • Kaletra oral solution from Tier 2 to Tier 3

Preauthorization Update

  • Stimate nasal solution, Soriatane (acitretin), Cystadane, Adagen, Synribo, Opsumit, Sucraid, and Kuvan add preauthorization
  • Fluocinonide cream, Vanos, Ultresa, Viokace add medical necessity preauthorization

Quantity Limit Update

  • Emend (Aprepitant) oral capsule, Concerta (methylphenidate ER), Vyvanse, Zydelig add quantity limit
  • Sutent, Tykerb, Byetta, Anzemet,  update quantity limit

See the PacificSource Drug Lists page for the current drug list.

May 2017. The following changes to the drug list are effective May 22, 2017:

Formulary Additions

  • Rhofade add Tier 3 with medical necessity preauthorization
  • Olmesartan tablet add Tier 1
  • Zamicet add Tier 3 with quantity limit
  • Synjardy add Tier 2 with quantity limit

Tier Change

  • Farxiga, Xigduo XR, Jardiance, Glyxambi from Tier 3 to Tier 2
  • Benicar from Tier 2 to Tier 3; consider Olmesartan
  • Invokana, Invokamet, Invokamet XR from Tier 2 to Tier 3 add medical necessity preauthorization

Preauthorization Update

  • Metaxalone tablet, Carisoprodol-aspirin tablet, Capital-Codeine suspension, Tizanidine capsule (Zanaflex), add medical necessity preauthorization
  • Xartemis XR, Primlev, Percocet, Zebutal, Vimovo, Vanatol LQ add medical necessity preauthorization

Quantity Limit Update

  • Lidocaine-Prilocaine cream, Lidocaine ointment, Lidocaine gel, Lidocaine-Tetracaine cream (Pliaglis cream), Lidocaine lotion add quantity limit
  • Diclofenac with Misoprostol delayed release tablet (Arthrotec), Hydrocodone-Acetaminophen tablet/solution (Xodol, Norco), Acetaminophen-Codeine solution, Pentazocine-Naloxone tablet, Tramadol-Acetaminophen (Ultracet), Butalbital-Acetaminophen-Caffeine (Esgic) add quantity limit

See the PacificSource Drug Lists page for the current drug list.

State-based Drug List (ID, MT, OR) Changes

June 2017. The following changes to the drug list are effective June 22, 2017:

Formulary Additions

  • Kisqali tablet add Tier 4 with preauthorization
  • Orkambi add Tier 4 with preauthorization
  • Vyvanse chewable tablet add Tier 3
  • Rasagiline, Abacavir-Lamivudine tablet, Mimvey Lo, Lopinavir-Ritonavir solution, Yuvafem, Nitroglycerin sublingual tablet, Triamcinolone Acetonide Aerosol Solution, Ezetimibe, Erythromycin suspension, Amabelz, Lopreeza add Tier 1
  • Camrese Lo, Norethindrone Acet-Ethinyl Est, Norethin-Eth Estradiol-FE, Ethynodiol Diac- Eth Estradiol, Estarylla, Drospirenone-Eth Estrad-Levomefol, Larin 1/20, Rajani, Zenchent FE, Wymzya Fe add Tier 0
  • Valganciclovir solution, Levalbuterol Tartrate Aerosol, Aprepitant, Dexmethylphenidate ER, Oseltamivir, Epinephrine Solution Auto-injector add Tier 1 with quantity limit

Removed from Formulary

  • Valcyte; consider Valganciclovir
  • Tamiflu; consider Oseltamivir
  • Emend; consider Aprepitant
  • Nitrostat; consider nitroglycerin SL tablet
  • Kaletra solution; consider Lopinavir-ritonavir solution
  • Focalin XR; consider dexmethylphenidate SR
  • Veltin gel, Ziana gel; consider Clindamycin-Tretinoin gel
  • Vagifem; consider Yuvafem
  • Amoxicillin-Clarithromycin-Lansoprazole therapy pack; consider amoxicillin, clarithromycin, lansoprazole separately
  • Kenalog; consider triamcinolone Acetonide aerosol solution
  • EryPed 200, E.E.S. Granules; consider Erythromycin suspension
  • Voltaren gel; consider diclofenac 1% gel
  • Azilect; consider Rasagiline tablet
  • Betamethasone valerate 0.12% foam; consider betamethasone cream
  • Epzicom; consider Abacavir-Lamivudine
  • Zetia; consider ezetimibe
  • Xopenex HFA; consider Levalbuterol
  • Beyaz; consider Rajani
  • Benicar; consider Olmesartan

Preauthorization Update

  • Acitretin, Sodium Phenylbutyrate add preauthorization

Quantity Limit update

  • Zolinza, Synarel, Cabergoline add quantity limit
  • Sutent, Tykerb, Byetta update quantity limit

See the PacificSource Drug Lists page for the current drug list.

May 2017. The following changes to the drug list are effective May 22, 2017:

Formulary Additions

  • Olmesartan add Tier 1 with step therapy
  • Synjardy add Tier 2 with quantity limit

Removed from Formulary

  • Primlev; consider oxycodone-acetaminophen tablet
  • Invokana; consider Jardiance
  • Invokamet; consider Jardiance, Farxiga

Tier Change

  • Farxiga, Xigduo XR, Jardiance, Glyxambi from Tier 3 to Tier 2
  • Suboxone from Tier 2 to Tier 3

Quantity Limit update

  • Lidocaine gel, solution, lidocaine-tetracaine topical patch add quantity limit
  • Hydrocodone-Acetaminophen tablet update quantity limit

See the PacificSource Drug Lists page for the current drug list.

“Partial Fill” Lets a Patient Test a New Prescription

As you know, some drugs not only have a high cost, but have side effects that make them hard to tolerate for long-term use. Beginning February 22, 2016, these medications will be dispensed in a limited amount, on the first fill only, for half the normal copay. This “partial fill” will act as a trial period to see if the patient is able to successfully take the drug. 

A week into the first fill, a Caremark Specialty Care Team pharmacist or nurse will contact the patient. They will check on side effects and see if the patient was able to tolerate the drug. The Care Team will also answer questions and concerns about the treatment. If the trial period is a success, the patient will continue the drug. After this initial trial, all future fills will be for the full amount. 

On our drug lists, partial-fill drugs are identified by “Partial Fill” in the Restrictions column.

Partial-fill drugs include:

  • Afinitor
  • Bosulif
  • Erivedge
  • Gleevec
  • Inlyta
  • Jakafi
  • Nexavar
  • Odomzo
  • Sprycel
  • Sutent
  • Tafinlar
  • Tarceva
  • Targretin
  • Tasigna
  • Votrient
  • Xalkori
  • Xtandi
  • Zolinza
  • Zykadia
  • Zytiga

Preauthorization and Step Therapy Drug Lists with Criteria

Our Preauthorization Policies and Step Therapy Policies documents contain lists of drugs that require preauthorization or that are Step Therapy drugs, as well as their criteria. These two documents replace the one-page "PDL/VDL Preauthorization and Step Therapy Drug Lists" document. You may also use Preauthorization Policies to access our coverage rules for compound medications.

Flu and Pertussis Vaccination Coverage

Our flu vaccination page now includes information about your coverage for whooping cough (pertussis), as well as seasonal flu vaccination and general information.

Consumer Updates from the FDA

Quick Links

PacificSource Drug Lists—our comprehensive drug list page

Preventive Drug List

Incentive Drug List

Prescription drug claim form

Prescription Drug Preauthorization Request (Fax)

InTouch for Members

Are you a Medicare or Medicaid member?

If so, we have a website just for you!

Cool Tools for Managing Your Rx

On the CVS Caremark® website, you'll find tools to help you track pharmacy expenses, save on drug costs, manage your prescriptions, and more. Register by using the member ID number and group code on your ID card. To start, visit Caremark.com.

Why Choose Generics?

Generic prescription medicines are safe, effective, and a good value. Save money by using them instead of brand name drugs whenever possible.

Questions?

Contact our Pharmacy Services Department:

  • Phone: (541) 225-3784
  • Toll-free: (800) 624-6052, ext. 3784
  • Email: Use our online Contact Us form
Last updated 5/19/2017